Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.32 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.32 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.32 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.32 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.32 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29728023 | 1.00 | ALDH1A1 (0.33) | ALDH1A1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL1799946 | 0.87 | PSEN1 (0.33) | ALDH1A1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL12863946 | 0.86 | CHRNA1 (0.30) | ALDH1A1 | |
| SCHEMBL28892113 | 0.85 | HTT (0.34) | ALDH1A1 | |
| SCHEMBL1801176 | 0.84 | ALDH1A1 (0.34) | ALDH1A1KDM1AMEN1KMT2AATM | |
| SCHEMBL12056328 | 0.84 | — | — | |
| SCHEMBL2893249 | 0.83 | ALDH1A1 (0.35) | ALDH1A1MAPTMEN1KMT2AATM | |
| SCHEMBL3025243 | 0.82 | L3MBTL1 (0.42) | ALDH1A1KDM1AMAPTMEN1KMT2A | |
| SCHEMBL28892326 | 0.82 | PSEN1 (0.31) | ALDH1A1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL28892260 | 0.81 | CYP1A2 (0.33) | ALDH1A1TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4275493-A1 | FORMULATION OF INSECTICIDAL MIXTURES COMPRISING GLYCOL ETHER SOLVENTS | Bayer Aktiengesellschaft (DE) | 2023-11-15 | — | — | EP | claimed |
| US-20230068010-A1 | FORMULATION OF INSECTICIDAL MIXTURES COMPRISING GLYCOL ETHER SOLVENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-03-02 | — | — | US | claimed |
| EP-3772943-A1 | FORMULATION OF INSECTICIDAL MIXTURES COMPRISING PROPYLENE CARBONATE | Bayer Aktiengesellschaft (DE) | 2021-02-17 | — | — | EP | claimed |
| WO-2019197635-A1 | FORMULATION OF INSECTICIDAL MIXTURES COMPRISING PROPYLENE CARBONATE | BAYER AKTIENGESELLSCHAFT (DE) | 2019-10-17 | — | — | WO | claimed |
| EP-4275493-A1 | FORMULATION OF INSECTICIDAL MIXTURES COMPRISING GLYCOL ETHER SOLVENTS | Bayer Aktiengesellschaft (DE) | 2023-11-15 | — | — | EP | disclosed |
| US-20230068010-A1 | FORMULATION OF INSECTICIDAL MIXTURES COMPRISING GLYCOL ETHER SOLVENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-03-02 | — | — | US | disclosed |
| WO-2021069628-A1 | FORMULATION OF INSECTICIDAL MIXTURES COMPRISING GLYCOL ETHER SOLVENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2021-04-15 | — | — | WO | disclosed |
| EP-3772943-A1 | FORMULATION OF INSECTICIDAL MIXTURES COMPRISING PROPYLENE CARBONATE | Bayer Aktiengesellschaft (DE) | 2021-02-17 | — | — | EP | disclosed |
| WO-2019197635-A1 | FORMULATION OF INSECTICIDAL MIXTURES COMPRISING PROPYLENE CARBONATE | BAYER AKTIENGESELLSCHAFT (DE) | 2019-10-17 | — | — | WO | disclosed |
| US-9550745-B2 | Method for preparing 4-aminobut-2-enolides | BAYER CROPSCIENCE AG (DE) | 2017-01-24 | — | — | US | disclosed |
| EP-2193128-B1 | METHOD FOR MANUFACTURING 4-AMINOBUT-2-ENOLIDS | BAYER IP GMBH (DE) | 2016-10-26 | — | — | EP | disclosed |
| EP-2516421-B1 | New method of producing 4-aminobut-2-enolides starting from 4-alkoxyfuran-2(5H)-one or 4-arylalkoxyfuran-2-(5H)-one | BAYER IP GMBH (DE) | 2016-08-10 | — | — | EP | disclosed |
| US-20090253749-A1 | SUBSTITUTED ENAMINOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG | 2009-10-08 | — | — | US | disclosed |
| EP-2042496-A1 | Method for manufacturing 4-aminobut-2-enolids | Bayer CropScience AG (DE) | 2009-04-01 | — | — | EP | disclosed |
| WO-2009036899-A1 | METHOD FOR PRODUCING 4-AMINOBUT-2-ENOLIDES | BAYER CROPSCIENCE AG (DE) | 2009-03-26 | — | — | WO | disclosed |
| WO-2009036898-A1 | METHOD FOR PRODUCING 4-AMINOBUT-2-ENOLIDES | BAYER CROPSCIENCE AG (DE) | 2009-03-26 | — | — | WO | disclosed |
| EP-2039678-A1 | Method for manufacturing 4-aminobut-2-enolids | Bayer CropScience AG (DE) | 2009-03-25 | — | — | EP | disclosed |
| EP-2004635-A1 | SUBSTITUTED ENAMINOCARBONYL COMPOUNDS | Bayer CropScience AG (DE) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007115644-A1 | SUBSTITUTED ENAMINOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007115644-A1 | SUBSTITUTED ENAMINOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2007-10-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230068010-A1 | FORMULATION OF INSECTICIDAL MIXTURES COMPRISING GLYCOL ETHER SOLVENTS | SGMS2, SGMS1, CYP51A1 | ALDH1A1 3100/4885PSEN1 1250/4885PSEN2 1366/4885 |
| US-20090253749-A1 | SUBSTITUTED ENAMINOCARBONYL COMPOUNDS | DDT, NPEPPS, L3MBTL4 | ALDH1A1 4014/4885PSEN1 2614/4885PSEN2 2429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.